From a biochemical pharmacy viewpoint, Relafen 750 (nabumetone) represents a fascinating case of a non-copyrightal anti-inflammatory medication that undergoes significant metabolism within the body. Its initial intake isn't directly responsible for its primary effect ; instead, it’s converted to its active metabolite, the active form, which exert